H.pylori gastric adenocarcinoma pathophysiology
Helicobacter pylori infection Microchapters |
Differentiating Helicobacter pylori infection from other Diseases |
---|
Diagnosis |
Guideline Recommendation |
Treatment |
Case Studies |
H.pylori gastric adenocarcinoma pathophysiology On the Web |
American Roentgen Ray Society Images of H.pylori gastric adenocarcinoma pathophysiology |
Directions to Hospitals Treating Helicobacter pylori infection |
Risk calculators and risk factors for H.pylori gastric adenocarcinoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]
Overview
Pathophysiology
- Gastric cancer is the second leading cause of cancer-related deaths worldwide and H.pylori is the strongest known risk factor for gastric cancer.[1]
- H.pylori is considered as Type I carcinogen. Among infected individuals, 1 to 3% develop gastric adenocarcinoma.
Pathogenesis
References
- ↑ Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M; et al. (2001). "Helicobacter pylori infection and the development of gastric cancer". N Engl J Med. 345 (11): 784–9. doi:10.1056/NEJMoa001999. PMID 11556297.